1,469 results match your criteria: "Neurosarcoidosis"
Neurol Sci
December 2024
Department of Neurology, Fleni, Fleni Montañeses 2325, Buenos Aires, 1428, Argentina.
Zh Nevrol Psikhiatr Im S S Korsakova
December 2024
Federal Center of Brain Research and Neurotechnologies of the Federal Medical Biological Agency, Moscow, Russia.
Objective: To present a case series analysis of surgical treatment of patients with secondary trigeminal neuralgia.
Material And Methods: The treatment of 8 patients with secondary trigeminal neuralgia who underwent surgery since 2021 was analyzed. All records, neuroimaging archive, and follow-up observations were reviewed.
Postep Psychiatr Neurol
September 2024
Department of Medical Virology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Purpose: Sarcoidosis, a multi-organ granulomatous disease, occasionally involves the nervous system, presenting as neurosarcoidosis. The following case demonstrates a potential association between COVID-19 and brain and spinal cord injury mimicking neurosarcoidosis.
Case Description: A 51-year-old woman presented with persistent holocranial headache, nausea, vertigo, and neurological deficits one month after a COVID-19 hospitalization.
Sarcoidosis is an immune-mediated multisystem condition of unknown etiology, characterized by non-caseating granulomatous inflammation. While it commonly affects the lungs and the reticuloendothelial system, it can affect any organ. Most of such cases involve the central nervous system, but the condition rarely presents with symptoms related to hypothalamic-pituitary dysfunction.
View Article and Find Full Text PDFNeurosarcoidosis, particularly in the absence of extra-neurologic systemic manifestations of sarcoidosis, is a challenging diagnosis that has a wide array of presentations. Most often presenting with cranial neuropathies, basilar meningitis or pituitary/hypothalamic dysfunction, isolated involvement of the spinal cord without cranial manifestations is exceptionally rare, often involving intramedullary lesions. Here, we present the unique case of a 64-year-old female with atypical neurosarcoidosis presenting with myelopathy from extra-dural nodules without other neurologic or systemic symptoms.
View Article and Find Full Text PDFCureus
November 2024
Department of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, USA.
Primary hemophagocytic lymphohistiocytosis (HLH) is a rare, often fatal immune disorder characterized by an overactivation of the immune system. This disease is more common in children but has been known to occur in the occasional adult. The criteria for diagnosis in children do not correlate well with diagnosis in adults, and the numerous variations of presentation in adults often lead to a delay in diagnosis and treatment initiation.
View Article and Find Full Text PDFJ Clin Med
November 2024
Department of Pharmacology, Institute of Pharmacy, I.M. Sechenov First Moscow State Medical University, Moscow 119991, Russia.
Pediatr Neurol
January 2025
Department of General Pediatrics, Pediatric Internal Medicine, Rheumatology and Infectious Diseases, National Reference Centre for Rare Pediatric Inflammatory Rheumatisms and Systemic Autoimmune Diseases (RAISE), Robert-Debré University Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France; Université Paris Cité, INSERM, Centre de Recherche sur l'inflammation UMR 1149, Paris, France. Electronic address:
Acta Neurol Belg
November 2024
Department of Internal Medicine and Infectious Diseases, Cliniques Universitaires Saint-Luc, UCLouvain, Avenue Hippocrate 10, 1200, Brussels, Belgium.
Int J Rheum Dis
November 2024
Division of Allergy, Immunology and Rheumatology, Department of Internal Medicine, Changhua Christian Hospital, Changhua, Taiwan.
Front Immunol
October 2024
Department of Neurology, Brain Research Institute, Niigata University, Niigata, Japan.
Progressive multifocal leukoencephalopathy (PML) is a rare central nervous system disease caused by JC virus (JCV) infection. Human immunodeficiency virus (HIV) infection is the greatest risk factor for PML. Other immunological diseases, including systemic sarcoidosis, have also been reported as risk factors for PML.
View Article and Find Full Text PDFDiagnostics (Basel)
October 2024
Rheumatology Unit, Carmel Medical Center, Haifa 3436212, Israel.
Cureus
September 2024
Internal Medicine, Rawalpindi Medical University, Rawalpindi, PAK.
Cureus
September 2024
Internal Medicine, Ittefaq Hospital, Lahore, PAK.
J Autoimmun
December 2024
Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
Cureus
August 2024
Internal Medicine, Rochester Regional Health, Rochester, USA.
Neurology
November 2024
From the Department of Neurology, University of Pittsburgh Medical Center, PA.
Am J Med Sci
September 2024
Department of Neurology, Louisiana State University Health Sciences Center, Shreveport, USA.
Lancet Neurol
October 2024
Department of Neurobiology & Neuroscience Institute, Morehouse School of Medicine, Atlanta, GA, USA.
The differential diagnosis of suspected multiple sclerosis has been developed using data from North America, northern Europe, and Australasia, with a focus on White populations. People from minority ethnic and racial backgrounds in regions where prevalence of multiple sclerosis is high are more often negatively affected by social determinants of health, compared with White people in these regions. A better understanding of changing demographics, the clinical characteristics of people from minority ethnic or racial backgrounds, and the social challenges they face might facilitate equitable clinical approaches when considering a diagnosis of multiple sclerosis.
View Article and Find Full Text PDFNMC Case Rep J
August 2024
Department of Neurosurgery, Sapporo Medical University Hospital, Sapporo, Hokkaido, Japan.
Neurosarcoidosis is a condition that is characterized by the occurrence of noncaseating epithelioid granulomas in various organs throughout the body, including the lungs, heart, and central nervous system. It is particularly prevalent in cases of noncommunicating hydrocephalus. While its clinical presentations may vary, neurological deficits such as hemiparesis are extremely uncommon.
View Article and Find Full Text PDFNeurology
October 2024
From the Department of Neurology, Mayo Clinic, Rochester, MN.
Brain Behav
September 2024
Service de Neurologie, Institut du Thorax et du Système Nerveux, CRC-SEP, CHU Nantes, Nantes Université, Nantes, France.
Introduction: Neurosarcoidosis (NS) is a systemic inflammatory granulomatous disease affecting of patients with sarcoidosis. Its diagnosis is difficult as there is no specific test for it. Because of its rarity, the management of NS has so far only been described in case series and short retrospective cohorts.
View Article and Find Full Text PDFJ Clin Med
August 2024
Department of Neurology, Henry Ford Health, Detroit, MI 48202, USA.
Cureus
August 2024
Rheumatology, University of Maryland School of Medicine, Baltimore, USA.
Sarcoidosis is a systemic inflammatory disease that affects diverse organs such as the lungs, skin, eyes, and brain. Osseous involvement in sarcoidosis usually affects bones of the appendages with direct infiltration of non-caseating granulomas without bony infarcts. Symptoms of sarcoid bone lesions respond well to corticosteroid therapy.
View Article and Find Full Text PDFNat Rev Drug Discov
November 2024
Institute for inflammatory and infectious diseases, INSERM UMR1291 - CNRS UMR505, Toulouse, France.
In neuroinflammatory diseases, systemic (blood-borne) leukocytes invade the central nervous system (CNS) and lead to tissue damage. A causal relationship between neuroinflammatory diseases and dysregulated cytokine networks is well established across several preclinical models. Cytokine dysregulation is also observed as an inadvertent effect of cancer immunotherapy, where it often leads to neuroinflammation.
View Article and Find Full Text PDF